These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12743622)

  • 41. Changes of hepatic lipid mediators associated with intake of high-fat diet for 12 weeks in endotoxemic rats using LC-ESI-MS/MS.
    Nishiokada A; Miyoshi M; Fujiwara M; Aoyama-Ishikawa M; Maeshige N; Takahashi M; Hamada Y; Usami Y; Honda M; Arita M; Usami M
    Clin Nutr; 2015 Aug; 34(4):685-93. PubMed ID: 25131602
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of cobalt protoporphyrin on hepatic drug-metabolizing enzymes. Specificity for cytochrome P-450.
    Spaethe SM; Jollow DJ
    Biochem Pharmacol; 1989 Jun; 38(12):2027-38. PubMed ID: 2742604
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro metabolism of tirilazad mesylate in male and female rats. Contribution of cytochrome P4502C11 and delta 4-5 alpha-reductase.
    Wienkers LC; Steenwyk RC; Mizsak SA; Pearson PG
    Drug Metab Dispos; 1995 Mar; 23(3):383-92. PubMed ID: 7628305
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of lipopolysaccharide on TNF-alpha production, hepatic NOS2 activity, and hepatic toxicity in rats with cirrhosis.
    Heller J; Sogni P; Barrière E; Tazi KA; Chauvelot-Moachon L; Guimont MC; Bories PN; Poirel O; Moreau R; Lebrec D
    J Hepatol; 2000 Sep; 33(3):376-81. PubMed ID: 11019992
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Endotoxin-mediated disturbance of hepatic cytochrome P450 function and development of endotoxin tolerance in the rat model of dextran sulfate sodium-induced experimental colitis.
    Masubuchi Y; Horie T
    Drug Metab Dispos; 2004 Apr; 32(4):437-41. PubMed ID: 15039297
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro and in vivo study of the effects of enrofloxacin on hepatic cytochrome P-450. Potential for drug interactions.
    Vancutsem PM; Babish JG
    Vet Hum Toxicol; 1996 Aug; 38(4):254-9. PubMed ID: 8829341
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of the impact of Polygonum capitatum, a traditional Chinese herbal medicine, on rat hepatic cytochrome P450 enzymes by using a cocktail of probe drugs.
    Zheng L; Lu Y; Cao X; Huang Y; Liu Y; Tang L; Liao SG; Wang AM; Li YJ; Lan YY; Wang YL
    J Ethnopharmacol; 2014 Dec; 158 Pt A():276-82. PubMed ID: 25446640
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of naturally occurring plant phenolics on the induction of drug metabolizing enzymes by o-toluidine.
    Szaefer H; Jodynis-Liebert J; Cichocki M; Matuszewska A; Baer-Dubowska W
    Toxicology; 2003 Apr; 186(1-2):67-77. PubMed ID: 12604171
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of muroctasin on the activities of drug metabolizing enzymes in liver microsomes of rats.
    Kamataki T; Komori M; Iwasaki M; Ohi H; Kitada M; Miura T; Ono K
    Arzneimittelforschung; 1988 Jul; 38(7A):1019-22. PubMed ID: 3263867
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential effect of pentoxifylline on lipopolysaccharide-induced downregulation of cytochrome P450.
    Monshouwer M; McLellan RA; Delaporte E; Witkamp RF; van Miert AS; Renton KW
    Biochem Pharmacol; 1996 Oct; 52(8):1195-200. PubMed ID: 8937426
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mechanism for hepato-protective action of Liangxue Huayu Recipe (LHR): blockade of mitochondrial cytochrome c release and caspase activation.
    Jiang ZQ; Yan XJ; Bi L; Chen JP; Zhou Q; Chen WP
    J Ethnopharmacol; 2013 Jul; 148(3):851-60. PubMed ID: 23711831
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enalapril hepatotoxicity in the rat. Effects of modulators of cytochrome P450 and glutathione.
    Jurima-Romet M; Huang HS
    Biochem Pharmacol; 1992 Nov; 44(9):1803-10. PubMed ID: 1449535
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intracerebroventricular passive immunization. I. The effect of intracerebroventricular administration of an antiserum to tumor necrosis factor-alpha on the plasma adrenocorticotropin response to lipopolysaccharide in rats.
    Turnbull AV; Rivier CL
    Endocrinology; 1998 Jan; 139(1):119-27. PubMed ID: 9421406
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of training and anabolic-androgenic steroids on drug metabolism in rat liver.
    Saborido A; Molano F; Megías A
    Med Sci Sports Exerc; 1993 Jul; 25(7):815-22. PubMed ID: 8350704
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of Kupffer cells and TNF-alpha in monocrotaline and bacterial lipopolysaccharide-induced liver injury.
    Yee SB; Ganey PE; Roth RA
    Toxicol Sci; 2003 Jan; 71(1):124-32. PubMed ID: 12520082
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Studies on the metabolism of aminopyrine, antipyrine and theophylline using monoclonal antibodies to cytochrome P-450 isozymes purified from rat liver.
    Slusher LB; Park SS; Gelboin HV; Vesell ES
    Biochem Pharmacol; 1987 Jul; 36(14):2359-67. PubMed ID: 2440440
    [TBL] [Abstract][Full Text] [Related]  

  • 57. AM3 (Inmunoferón) as an adjuvant to hepatitis B vaccination in hemodialysis patients.
    Pérez-García R; Pérez-García A; Verbeelen D; Bernstein ED; Villarrubia VG; Alvarez-Mon M
    Kidney Int; 2002 May; 61(5):1845-52. PubMed ID: 11967036
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Protective effect of Linomide on TNF-alpha-induced hepatic injury.
    Klintman D; Hedlund G; Thorlacius H
    J Hepatol; 2002 Feb; 36(2):226-32. PubMed ID: 11830334
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hepatic drug metabolizing profile of Flinders Sensitive Line rat model of depression.
    Kotsovolou O; Ingelman-Sundberg M; Lang MA; Marselos M; Overstreet DH; Papadopoulou-Daifoti Z; Johanson I; Fotopoulos A; Konstandi M
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):1075-84. PubMed ID: 20595028
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Endotoxin administration to humans inhibits hepatic cytochrome P450-mediated drug metabolism.
    Shedlofsky SI; Israel BC; McClain CJ; Hill DB; Blouin RA
    J Clin Invest; 1994 Dec; 94(6):2209-14. PubMed ID: 7989576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.